Customer Care Tel: 0161 483 5884
Email: ukcustomer@alere.com
Website: www.alere.co.uk

Connecting withPrimary Care Services

Product Areas


Member login

Clearview® Chlamydia MF

The Clearview®Chlamydia test is a rapid immunoassay for the detection of the Chlamydia trachomatisantigen. The test can be performed alongside the patient, with results available during the same patient visit. Such a simple rapid diagnostic test is now an essential tool in the effective management of Chlamydia.

The Clearview Chlamydia test provides quick and accurate detection of chlamydial infection in both male and females (MF). Successful management of women with Chlamydia infection or pelvic inflammatory disease (PID) is frequently dependent on the treatment of the infecting partner. For this reason, the dual application of Clearview Chlamydia MF* is highly significant. Clearview Chlamydia's high predictive value for positive and negative results offers a simple and practical opportunity for improving patient care. In addition, the Clearview Chlamydia test combines excellent specificity with a high predictive value for a positive result. This helps providers improve patient care in a simple and practical way.

Patient benefits of the Clearview Chlamydia MF test include:

  • Diagnosis and treatment that can be initiated during the same patient visit
  • The ability to stem the development of PID and other complications at an early stage
  • Prevention of unnecessary anxiety waiting for test results
  • Greater peace of mind that comes with receiving targeted therapy
  • Improved quality of care through appropriate counselling at the time of diagnosis
Clearview Chlamydia MF pack and contents
loading